Methyl 3,4,5,6-tetrachloropicolinate

Catalog No. :
ACELWM298
CAS No. :
35592-96-2
Molecular Formula :
C7H3Cl4NO2
Molecular Weight :
274.92

IUPAC Name:methyl 3,4,5,6-tetrachloropicolinate

Methyl 3,4,5,6-tetrachloropicolinate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$194.00Login to see priceInquiryInquiry
250mg98%$310.00Login to see priceInquiryInquiry
1g98%$697.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3,4,5,6-tetrachloropicolinate
IUPAC Namemethyl 3,4,5,6-tetrachloropicolinate
MDL No.MFCD00184239
Molecular FormulaC7H3Cl4NO2
Molecular Weight274.92
SMILESO=C(C1=NC(Cl)=C(Cl)C(Cl)=C1Cl)OC
InChI KeyRYIFDLNTADZCRH-UHFFFAOYSA-N
SynonymMETHYL 3,4,5,6-TETRACHLOROPYRIDINE-2-CARBOXYLATE;3,4,5,6-TETRACHLORO-PYRIDINE-2-CARBOXYLIC ACID METHYL ESTER;2-Pyridinecarboxylic acid, 3,4,5,6-tetrachloro-, methyl ester;Regorafenib Impurity 52;Methyl-3,4,5,6-tetrachloropicolinate (Regorafenib Impurity)
CAS No.35592-96-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACELWM298 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNESY751 route compound structure diagram
    ACNESY75110469-09-7 In Stock
  2. Then
  3. ACELWM298 route product structure diagram
    ACELWM29835592-96-2
Inquiry

2. ACELWM298 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACNESY751 route compound structure diagram
    ACNESY75110469-09-7 In Stock
  4. Then
  5. ACELWM298 route product structure diagram
    ACELWM29835592-96-2
Inquiry

Comments (0)